Injectable glutathione delivers higher blood concentrations and bypasses digestive breakdown, creating greater pharmacological effect and safety riskthis triggers classification as an unapproved drug requiring prescriber oversight
Furthermore, it exhibits poor reactivity with certain antioxidant classes, such as thiols, and may not fully represent the complex interplay of antioxidants in biological systems (Benzie & Devaki, 2017)
Vienne MP, Ochando N, Borrel MT, Gall Y, Lauze C, Dupuy P
Taking a pill that is unregulated by the FDA and has a high concentration of glutathione can present risks. In the current study, Harris team used advanced technology to search for therapies that could inhibit a tumors ability to use glutathione